Since this species has only recently been identified clinical features are described in the page on Plasmodium ovale.

This species separated from its closest known relative - Plasmodium ovale curtisi - between 1.0 and 3.5 million years ago.

This species is related to Plasmodium ovale and Plasmodium simiovale.

Plasmodium ovale curtisi (another, less frequent, cause of benign tertian malaria)

Plasmodium ovale is a species of parasitic protozoa that causes tertian malaria in humans.

The parasite resembles both Plasmodium vivax and Plasmodium ovale.

Plasmodium knowlesi is the sixth major human malaria parasite (following the division of Plasmodium ovale into 2 species).

Two chimpanzee samples tested positive for Plasmodium ovale and one for Plasmodium malariae.

The tissue form of Plasmodium ovale was described in 1954 and that of P. malariae in 1960 in experimentally infected chimpanzees.

Benign tertian malaria (malaria caused specifically by Plasmodium vivax or Plasmodium ovale)

These species are Plasmodium ovale curtisi and Plasmodium ovale wallikeri.

Schüffner's dots refers to a hematological finding that is associated with malaria, exclusively found in Plasmodium ovale and Plasmodium vivax.

In the species Plasmodium ovale and Plasmodium vivax, but not in Plasmodium malariae, hypnozoites have been shown to occur.

Pamaquine is no longer available anywhere, but primaquine is still used routinely worldwide as part of the treatment of Plasmodium vivax and Plasmodium ovale malaria.

There are four types of malaria: Plasmodium vivax, Plasmodium falciparum, Plasmodium malariae, and Plasmodium ovale.

The four species of malaria parasites infective to humans are Plasmodium falciparum,Plasmodium malariae, Plasmodium vivax & Plasmodium ovale.

Other blood sporozoans, such as Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae, that infect humans and cause malaria do not have such a productive cycle for invasion.

Malaria is caused by five Plasmodium species: Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae and Plasmodium knowlesi.

Plasmodium ovale has recently been shown to consist of two cocirculating species - Plasmodium ovale curtisi and Plasmodium ovale wallikeri.

In some Plasmodium species, such as Plasmodium vivax and Plasmodium ovale, the parasite in the hepatocyte may not achieve maturation to a schizont immediately but remain as a latent or dormant form called a hypnozoite.

The proposed indication for tafenoquine is for treatment of the hypnozoite stages of Plasmodium vivax (and also Plasmodium ovale) that are responsible for relapse of these malaria species even when the blood stages are successfully cleared.

It was described in 2010 when it was realised that Plasmodium ovale was in fact two distinct species - Plasmodium ovale curtisi and Plasmodium ovale wallikeri - which are morphologically identical.